CAPTRUST Financial Advisors
NVS icon

CAPTRUST Financial Advisors’s Novartis NVS Stock Holding History

CAPTRUST Financial Advisors’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.2M Buy
173,384
+12,376
+8% +$1.86M 0.04% 322
2026
Q1 		$24.6M Sell
161,008
-244
-0.2% -$37.4K 0.04% 316
2025
Q4 		$22.2M Buy
161,252
+7,103
+5% +$930K 0.04% 307
2025
Q3 		$19.8M Buy
154,149
+2,884
+2% +$352K 0.04% 320
2025
Q2 		$18.3M Buy
151,265
+11,674
+8% +$1.32M 0.04% 327
2025
Q1 		$15.6M Buy
139,591
+17,927
+15% +$1.91M 0.04% 334
2024
Q4 		$11.8M Sell
121,664
-9,381
-7% -$1M 0.03% 334
2024
Q3 		$15.1M Buy
131,045
+1,730
+1% +$196K 0.04% 290
2024
Q2 		$13.8M Buy
129,315
+2,534
+2% +$254K 0.04% 291
2024
Q1 		$12.3M Sell
126,781
-14,338
-10% -$1.47M 0.05% 309
2023
Q4 		$14.2M Buy
141,119
+747
+0.5% +$72.1K 0.05% 298
2023
Q3 		$14.3M Buy
140,372
+10,829
+8% +$1.1M 0.05% 260
2023
Q2 		$13.1M Buy
129,543
+15,196
+13% +$1.52M 0.05% 269
2023
Q1 		$10.5M Buy
114,347
+4,285
+4% +$374K 0.05% 285
2022
Q4 		$9.98M Sell
110,062
-744
-0.7% -$62.7K 0.05% 296
2022
Q3 		$8.42M Buy
110,806
+14,877
+16% +$1.23M 0.05% 295
2022
Q2 		$8.11M Buy
95,929
+9,410
+11% +$826K 0.05% 280
2022
Q1 		$7.59M Buy
86,519
+1,645
+2% +$142K 0.05% 276
2021
Q4 		$7.42M Buy
84,874
+1,975
+2% +$164K 0.05% 284
2021
Q3 		$6.78M Buy
82,899
+4,505
+6% +$405K 0.06% 268
2021
Q2 		$7.15M Sell
78,394
-2,691
-3% -$240K 0.07% 244
2021
Q1 		$6.93M Buy
81,085
+3,362
+4% +$302K 0.08% 232
2020
Q4 		$7.34M Buy
77,723
+2,259
+3% +$197K 0.1% 195
2020
Q3 		$6.59M Sell
75,464
-948
-1% -$82.1K 0.11% 184
2020
Q2 		$6.71M Buy
76,412
+3,455
+5% +$298K 0.11% 184
2020
Q1 		$5.9M Buy
72,957
+410
+0.6% +$36.6K 0.13% 175
2019
Q4 		$6.89M Buy
+72,547
New +$6.51M 0.11% 190

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

CAPTRUST Financial Advisors's NVS Position: Q2 2026 in Review

CAPTRUST Financial Advisors increased its Novartis (NVS) stake by 7.7% in Q2 2026, buying an estimated $1.86M and bringing the position to 173,384 shares worth $27.2M. The position accounts for 0.04% of the portfolio, ranked #322.

CAPTRUST Financial Advisors first reported a position in NVS in Q4 2019 and has held it in 27 quarters since. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • CAPTRUST Financial Advisors held 173,384 shares of Novartis worth $27.2M as of Q2 2026.
  • CAPTRUST Financial Advisors bought 12,376 Novartis shares in Q2 2026, an estimated $1.86M.
  • Novartis made up 0.04% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #322 holding.
  • CAPTRUST Financial Advisors first reported a position in Novartis in Q4 2019 and has held it in 27 quarters since.
  • 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.